Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolic-associated Fatty Liver Disease (MAFLD)”

60 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 60 results

Not applicableNot Yet RecruitingNCT07373769
What this trial is testing

Ultrasound Liver Imaging for Classification of Metabolic Dysfunction-associated Steatotic Liver Disease

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
University of British Columbia 145
Not applicableUnknownNCT06135467
What this trial is testing

Association Betweenq MAFLD ( Metabolic Associated Fatty Liver Disease) and Chronic Kidney Disease

Who this might be right for
Mafld in Ckd Patients
Assiut University 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT07024212
What this trial is testing

Phase II Study Evaluating the Efficacy and Safety of DR10624 Injection in MASLD and MetALD Subjects

Who this might be right for
MASLD
Zhejiang Doer Biologics Co., Ltd. 110
Not applicableNot Yet RecruitingNCT07053709
What this trial is testing

Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD)

Who this might be right for
Hyperuricemia and MAFLD
Assiut University 200
Not applicableLooking for participantsNCT05597709
What this trial is testing

Prevalence of MAFLD in Patients With Type 2 Diabetes in Jiangsu Province of China

Who this might be right for
Type 2 Diabetes Mellitus in RemissionMetabolic Associated Fatty Liver Disease
Wuxi Hisky Medical Technology Co Ltd 2,900
Not applicableUnknownNCT04861012
What this trial is testing

Screening for Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD) at Al-Rajhy Hospital Nutrition Clinic. Assiut, Egypt

Who this might be right for
Steatohepatitis, Nonalcoholic
Assiut University 360
Post-approval studies (Phase 4)Study completedNCT05474560
What this trial is testing

Febuxostat Versus Allopurinol on Hepatic Steatosis in MAFLD Patients

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseHyperuricemia
Ain Shams University 90
Not applicableLooking for participantsNCT05974904
What this trial is testing

Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver DiseaseHepatic SteatosisLiver Fibrosis
Chongqing Medical University 7,000
Not applicableUnknownNCT05804409
What this trial is testing

Screening for Pancreatic Exocrine Insufficieny in Metabolic Associated Fatty Liver Disease Patients

Who this might be right for
Pancreatic Exocrine Insufficiency
Assiut University 70
Not applicableStudy completedNCT07175688
What this trial is testing

Metabolic Associated Fatty Liver Disease and Pancreatic Steatosis in Obese Versus Lean Chronic Hepatitis B Patients

Who this might be right for
Metabolic Associated Fatty Liver DiseasePancreatic SteatosisObese+2 more
Tanta University 217
Not applicableUnknownNCT05880316
What this trial is testing

Prevalence of MAFLD Among Nurses and the Role of Intermittent Fasting

Who this might be right for
Fatty Liver Disease
Universiti Kebangsaan Malaysia Medical Centre 100
Not applicableUnknownNCT06078722
What this trial is testing

Evaluation of the Effectiveness of the Use of a Carnitine-Orotate Complex and Biphenyl Dimethyl Dicarboxylate in the Pathogenetic Therapy of Metabolic-associated Fatty Liver Disease: a Prospective Cohort Study

Who this might be right for
Metabolic-associated Fatty Liver Disease (MAFLD)
Kazakh Association of Internal Medicine Specialists 264
Not applicableNot Yet RecruitingNCT07391267
What this trial is testing

Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide.

Who this might be right for
Chronic Kidney DiseasesMAFLD
Institute of Liver and Biliary Sciences, India 90
Not applicableStudy completedNCT04761900
What this trial is testing

MAFLD-simplified Definition as an Optimized Risk Stratification Tool for Predicting Metabolic Outcomes

Who this might be right for
Metabolic Associated Fatty Liver Disease
Ningbo No. 1 Hospital 3,372
Not applicableLooking for participantsNCT06717828
What this trial is testing

The Effects of Tai Chi on Metabolic Dysfunction-associated Fatty Liver Disease in Middle-Aged and Older Adults

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Fujian Provincial Hospital 250
Not applicableStudy completedNCT06344364
What this trial is testing

Digital Pathology and AI for Liver Outcomes in MASLD

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease
PharmaNest, Inc 1,241
Not applicableNot Yet RecruitingNCT07177963
What this trial is testing

CPET-based HIIT for MAFLD

Who this might be right for
Metabolic Dysfunction-Associated Fatty Liver Disease
Tang Yida 54
Not applicableNot Yet RecruitingNCT06773221
What this trial is testing

The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis

Who this might be right for
Metabolic Dysfunction Associated Fatty Liver DiseaseCompensated Liver Cirrhosis
Beijing Friendship Hospital 195
Not applicableStudy completedNCT06492369
What this trial is testing

MAFLD Fibrosis Score for Detecting Fibrotic NASH in MAFLD Egyptian Patients

Who this might be right for
Metabolic- Associated Fatty Liver Disease (MAFLD)
Tanta University 382
Not applicableNot Yet RecruitingNCT07430501
What this trial is testing

Using Digital Twin Technology and Clinical Decision Support Systems to Improve the Early Detection, Personalised Treatment, and Long-term Monitoring of Patients Across the Full Spectrum of Metabolic-associated Fatty Liver Disease (MAFLD).

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Hospital Universitari Vall d'Hebron Research Institute 7,720
Load More Results